Sichuan Hebang Biotechnology Co Ltd (603077) - Total Assets
Based on the latest financial reports, Sichuan Hebang Biotechnology Co Ltd (603077) holds total assets worth CN¥29.64 Billion CNY (≈ $4.34 Billion USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Sichuan Hebang Biotechnology Co Ltd - Total Assets Trend (2009–2025)
This chart illustrates how Sichuan Hebang Biotechnology Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see 603077 market cap for the company's overall valuation and market capitalisation.
Sichuan Hebang Biotechnology Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Sichuan Hebang Biotechnology Co Ltd's total assets of CN¥29.64 Billion consist of 42.6% current assets and 57.4% non-current assets. Review 603077 total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 23.8% |
| Accounts Receivable | CN¥624.27 Million | 2.2% |
| Inventory | CN¥3.91 Billion | 13.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥1.14 Billion | 4.1% |
| Goodwill | CN¥1.78 Billion | 6.3% |
Asset Composition Trend (2009–2025)
This chart illustrates how Sichuan Hebang Biotechnology Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See today's stock price for Sichuan Hebang Biotechnology Co Ltd for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sichuan Hebang Biotechnology Co Ltd's current assets represent 42.6% of total assets in 2025, an increase from 22.9% in 2009.
- Cash Position: Cash and equivalents constituted 23.8% of total assets in 2025, up from 11.0% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 4.0% in 2009.
- Asset Diversification: The largest asset category is inventory at 13.9% of total assets.
Sichuan Hebang Biotechnology Co Ltd Competitors by Total Assets
Key competitors of Sichuan Hebang Biotechnology Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Methanex Corporation
TO:MX
|
Canada | CA$7.17 Billion |
|
Sichuan Em Technology Co Ltd
SHG:601208
|
China | CN¥11.08 Billion |
|
Tangshan Sunfar Silicon Ind
SHG:603938
|
China | CN¥3.42 Billion |
|
Solvac S.A.
BR:SOLV
|
Belgium | €2.73 Billion |
|
Robertet SA
PA:RBT
|
France | €1.00 Billion |
|
Anhui Hwasu Co.Ltd.
SHG:600935
|
China | CN¥9.31 Billion |
|
Shanghai Zhongyida Co Ltd A
SHG:600610
|
China | CN¥1.04 Billion |
|
Shandong Jincheng Pharmaceutical and Chemical Co Ltd
SHE:300233
|
China | CN¥5.21 Billion |
Sichuan Hebang Biotechnology Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.92 | 3.09 | 1.58 |
| Quick Ratio | 3.31 | 2.10 | 1.42 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥10.47 Billion | CN¥8.93 Billion | CN¥1.73 Billion |
Sichuan Hebang Biotechnology Co Ltd - Advanced Valuation Insights
This section examines the relationship between Sichuan Hebang Biotechnology Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.09 |
| Latest Market Cap to Assets Ratio | 0.10 |
| Asset Growth Rate (YoY) | -4.9% |
| Total Assets | CN¥28.21 Billion |
| Market Capitalization | $2.95 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Sichuan Hebang Biotechnology Co Ltd's assets below their book value (0.10x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Sichuan Hebang Biotechnology Co Ltd's assets decreased by 4.9% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Sichuan Hebang Biotechnology Co Ltd (2009–2025)
The table below shows the annual total assets of Sichuan Hebang Biotechnology Co Ltd from 2009 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥28.21 Billion ≈ $4.13 Billion |
-4.86% |
| 2024-12-31 | CN¥29.65 Billion ≈ $4.34 Billion |
+20.81% |
| 2023-12-31 | CN¥24.54 Billion ≈ $3.59 Billion |
+1.82% |
| 2022-12-31 | CN¥24.10 Billion ≈ $3.53 Billion |
+34.48% |
| 2021-12-31 | CN¥17.92 Billion ≈ $2.62 Billion |
+21.59% |
| 2020-12-31 | CN¥14.74 Billion ≈ $2.16 Billion |
+1.77% |
| 2019-12-31 | CN¥14.48 Billion ≈ $2.12 Billion |
+9.01% |
| 2018-12-31 | CN¥13.29 Billion ≈ $1.94 Billion |
+1.36% |
| 2017-12-31 | CN¥13.11 Billion ≈ $1.92 Billion |
+1.40% |
| 2016-12-31 | CN¥12.93 Billion ≈ $1.89 Billion |
+15.45% |
| 2015-12-31 | CN¥11.20 Billion ≈ $1.64 Billion |
+22.62% |
| 2014-12-31 | CN¥9.13 Billion ≈ $1.34 Billion |
+63.59% |
| 2013-12-31 | CN¥5.58 Billion ≈ $816.88 Million |
+10.62% |
| 2012-12-31 | CN¥5.05 Billion ≈ $738.45 Million |
+37.05% |
| 2011-12-31 | CN¥3.68 Billion ≈ $538.82 Million |
+18.06% |
| 2010-12-31 | CN¥3.12 Billion ≈ $456.38 Million |
-1.52% |
| 2009-12-31 | CN¥3.17 Billion ≈ $463.45 Million |
-- |
About Sichuan Hebang Biotechnology Co Ltd
Sichuan Hebang Biotechnology Corporation Limited provides agricultural, chemical, and new material products. It offers biological pesticides, biological veterinary drugs, and methionine products; and sodium carbonate, ammonium chloride, soda ash, diglyphosate, glyphosate, and brine. The company provides original glass and smart glass, special glass, low-e coated glass, ultra-high efficiency silic… Read more